Evaluation of some objective parameters for Ushna and Sheeta Gunas based on pharmacological study

Taste of phytocompounds: A better predictor for ethnopharmacological activities of medicinal plants than the phytochemical class?

ETHNOPHARMACOLOGICAL RELEVANCE

Understanding the patterns that shape traditional medical knowledge is essential for accelerating ethnopharmacological progress. According to Ayurveda, medicinal plants that belong to different taxa, but which have similar taste, may display similar (ethno)pharmacological activities (EPAs) (Bhishagratna, 1998; Sharma and Dash, 2006).

AIM OF THE STUDY

To understand the patterns that govern the distribution of herbal EPAs in Ayurveda and to evaluate the potential concordance between chemical class or taste of the constituent phytocompounds and EPAs.

MATERIAL AND METHODS

A mixed database (PhytoMolecularTasteDB) was constructed for Ayurvedic medicinal plants by integrating modern data (medicinal plant composition, phytochemical taste) with traditional data (ethnopharmacological activities of plant). PhytoMolecularTasteDB contains 431 Ayurvedic medicinal plants, 94 EPAs, 223 chemical classes of phytocompounds and 438 herbal tastants. Potential global or individual associations between chemical classes/taste of the phytoconstituents and EPAs were statistically analyzed.

RESULTS

There was no global statistical correlation between the various chemical classes of phytocompounds and EPAs, although there were several individual correlations. The results suggest the existence of a global statistical correlation (besides several individual correlations) between the plant "molecular taste" (various taste-based classes of phytocompounds) and EPAs.

CONCLUSIONS

These results suggest that phytochemical taste may be more relevant than chemical class for EPAs prediction.

Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats

Atherosclerosis is one of the most common disorders among the elderly. Depression may be associated with the development of atherosclerosis. Thus, the aim of this study is to evaluate and compare the effects of escitalopram (a selective serotonin reuptake inhibitor) with atorvastatin (a well known antihyperlipidemic drug) on high fat diet induced atherosclerosis in rats. The results of this study showed that the administration of either escitalopram or atorvastatin for 6 weeks was associated with a significant decrease in serum levels of total cholesterol, triglycerides, low density lipoproteins, very low density lipoproteins, and serum malondialdehyde, and a significant increase in high density lipoproteins when compared with the atherosclerosis model group. Histopathological examination of the aortas from the test rats revealed significant regression of atherosclerotic changes, together with a significant decrease in vascular cell adhesion molecule-1 (VCAM-1) expression in the media of both the escitalopram group and the atorvastatin group when compared with the atherosclerosis model group. This study has shown that escitalopram reduced atherosclerotic changes, thus its use as an antidepressant in elderly patients should be considered.